Term pregnancy in a patient with Crohn's disease under treatment with adalimumab [3];Gestación a término en paciente con enfermedad de Crohn en tratamiento con adalimumab

Gastroenterologia y Hepatologia

Volumn 28, Issue 7, 2005, Pages 435-

  Sanchez Munoz D ^a   Hoyas Pablos, E ^a   Ramirez Martin Del Campo, M ^a   Nunez Hospital D ^a   Guerrero Jimenez P ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; LETTER; PREGNANCY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

EID: 25144431522     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077767     Document Type: Letter

References (6)

1. Chew AL, Bennett A, Smith CH, Barker J, Kirkham B. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. Br J Dermatol. 2004;151:492-6.
2. Baraliakos X, Braun J. Current concepts in the therapy of the spondyloarthritides. BioDrugs. 2004;18:307-14.
3. Youdim A, Vasiliauskas EA, Targan SR, Papadakis KA, Ippoliti A, Dubinsky MC, et al. A pilot study of adalimumab in infliximab-allergic patients. Inflamm Bowel Dis. 2004;10:333-8.
4. Sandborn WJ, Hanauer S, Loftus EV Jr, Tremaine WJ, Kane S, Cohen R, et al. An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol. 2004;99:1984-9.
5. Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol. 2003;30:2563-71.
6. Product information: Humira®, adalimumab. Chicago: Abbott Laboratories, PI issued 12/2002; reviewed 12/2002.